跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PANTOPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PANTOPRAZOLE
Authorized
STANDARD
PANTOPRAZOLE
altamed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
df5af470d5ad6f7e
Company
altamed pharma
Type
Standard
Approval Details
Approval Id
df5af470d5ad6f7e
Drug Approval Canada Name
PANTOPRAZOLE
Product Name
PANTOPRAZOLE
Status
Marketed
Status Date
2019-03-08
Original Market Date
2019-03-08
Din
02469138
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC02 PANTOPRAZOLE
Atc Name
a 02 bc 02
Aig Number
0133229001
Company Name
altamed pharma
Company Address
151 Boulevard De Mortagne, Boucherville, Quebec, Canada, J4B 6G4
Active Ingredients
PANTOPRAZOLE (PANTOPRAZOLE SODIUM)
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
df5af470d5ad6f7e
Type
Standard
Back to Health Canada Approvals